8,11 Tirzepatide (Zepbound), a dual GLP-1/GIP RA, received FDA approval in November 2023 for chronic weight management in adults with obesity or overweight who have at least one weight-related comorbidity
[5] However, because it is not FDA-approved for therapeutic use in the United States, its administration is considered off-label or investigational, making medical supervision essential rather than optional
No Nausea, No Fatigue Vitamin B12 is a powerhouse in your body, keeping your blood and nerve cells healthy and functioning properly
Liu C, Fabius CD, Howard VJ, Haley WE, Roth DL
Low energy despite dieting and exercising
This diversity matters because psoriasis is not a single-mechanism disease